Pharma Articles
Articles are written by renowned pharmaceutical company executives and other professionals from across the world on important topics relating to the business. The part of articles on the pharmaceutical industry focuses on current and developing concerns in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
From Static PDFs to Usable Digital Forms in Pharmaceutical Operations
Walk through the quality compliance or operations function of almost any pharmaceutical manufacturer and youll find PDF forms everywhere from deviation reports change controls and training records to supplier questionnaires audit checklists and equipment logs Many of these documents exist as PDF fil...
Drug Approval Strategies and Regulatory Pathways in the Pharmaceutical Industry
Getting a new medicine to patients is never just a scientific achievement Its also a regulatory one A molecule can be brilliant in the lab and still stall for years if the drug approval process isnt planned properly from day one Thats why across the pharmaceutical industry regulatory strategy has qu...
Advanced 3D Cell Models: Moving from Promise to Practice in Drug Discovery
Over the past decade organoids spheroids and other advanced D cell models have transformed how researchers approach disease modelling and drug development Their ability to better reflect human biology than traditional D cultures has generated significant enthusiasm across pharmaceutical research yet...
Decision Integrity: The Layer ALCOA+ Was Never Built to Cover
When a model helps make a GxP call the data underneath it can be spotless and the decision still indefensible Here is where the gap opens and the controls that close it For years the discipline that has kept regulated records trustworthy is data integrity We learned ALCOA then ALCOA and built whole...
Digital Biomarkers and Wearables: Transforming Clinical Trial Data Collection
A participant enrolled in a week pharmaceutical trial may spend fewer than six hours inside a clinical site The remaining odd hours of that year the stairs the fatigue the broken nights the good days and the collapsed ones pass unrecorded Clinical development has quietly accepted this trade for de...
Data-Driven Pharma: Enterprise AI Strategies for R&D, Quality, and Operations
Few boardrooms in European pharma still need convincing that artificial intelligence matters The argument has moved on The uncomfortable question now facing chief executives chief scientific officers and heads of operations is why an organisation running eighty or ninety AI initiatives can rarely po...
Single-Use Technologies: Accelerating Flexible Biopharmaceutical Manufacturing
For most of the past two decades the case for singleuse technologies in biopharmaceutical manufacturing was argued in the language of the plant Disposable bags and flow paths removed cleaninplace and steaminplace loops shortened turnarounds and allowed engineers to stand up a suite without a validat...
Antibody-Drug Conjugates (ADCs): Driving the Next Generation of Precision Oncology
An antibodydrug conjugate is a targeted cancer therapy that links a potent cytotoxic drug to a monoclonal antibody through a chemical linker so the antibody delivers the payload directly to tumour cells expressing a chosen antigen The design widens the therapeutic window it concentrates cytotoxic ac...
Advanced Robotics and Autonomous Operations in Pharma Production
Walk the production floor of almost any modern European pharmaceutical site and you will find robots already at work Sixaxis arms denest syringe tubs Gantries load and unload lyophilisers Autonomous mobile units ferry pallets between the warehouse and the dispensary Robotics arrived in pharmaceutica...
Strategic Risk Management in Pharmaceutical Supply Networks
Ask a European pharmaceutical executive team how many qualified suppliers stand behind its ten highestvalue products and the answer arrives quickly and precisely Ask how many of those suppliers would still be shipping if a single industrial estate lost power for six weeks and the room falls silent T...
